High Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Isolates Recovered in Nigerian Hospitals in 2016 to 2020
Erkison Ewomazino Odih, Anderson O. Oaikhena, Anthony Underwood, Yaovi Mahuton Gildas Hounmanou, Oyinlola O. Oduyebo, Abayomi Fadeyi, Aaron O. Aboderin, Veronica O. Ogunleye, Silvia Argimón, Vitus Nnaemeka Akpunonu, Phillip O. Oshun, Abiodun Egwuenu, Tochi Okwor, Chikwe Ihekweazu, David M. Aanensen, Anders Dalsgaard, Iruka N. Okeke
Abstract
Acinetobacter baumannii bacteria are increasingly clinically relevant due to their propensity to harbor genes conferring resistance to multiple antimicrobials, as well as their ability to persist and disseminate in hospital environments and cause difficult-to-treat nosocomial infections. Little is known about the molecular epidemiology and antimicrobial resistance profiles of these organisms in Nigeria, largely due to limited capacity for their isolation, identification, and antimicrobial susceptibility testing. Our study characterized the diversity and antimicrobial resistance profiles of clinical A. baumannii in southwestern Nigeria using whole-genome sequencing. We also identified the key genetic elements facilitating the dissemination of carbapenem resistance genes within this species. This study provides key insights into the clinical burden and population dynamics of A. baumannii in hospitals in Nigeria and highlights the importance of routine whole-genome sequencing-based surveillance of this and other previously understudied pathogens in Nigeria and other similar settings.